China National Pharmaceutical Group Corporation (600420.SH): Sinopharm Rongsheng Vitamin B6 Injection has increased its specifications and passed the consistency evaluation.

Zhijing Finance and Economics APP News, China National Pharmaceutical Group Corporation (600420.SH) announced that recently, its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd. (referred to as China National Pharmaceutical Rongsheng), received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration. The approval is for the increase in specifications of Vitamin B6 injection solution and passing the generic drug quality and efficacy consistency evaluation (hereinafter referred to as consistency evaluation), and the issuance of a drug approval number.